Purpose. The emergence of carbapenem resistance in non-baumannii Acinetobacter has increased in clinical settings worldwide. We investigated the prevalence and mechanisms of carbapenem resistance in A. pittii and A. nosocomialis Thai isolates.
INTRODUCTION
Members of the Acinetobacter calcoaceticus-Acinetobacter baumannii (Acb) complex are common nosocomial pathogens. Acinetobacter baumannii, Acinetobacter calcoaceticus, Acinetobacter pittii, Acinetobacter nosocomialis, Acinetobacter seifertii and Acinetobacter dijkshoorniae belong to the Acb complex [1] . Although the prevalence and mortality rates of A. pittii and A. nosocomialis infections are lower than those of A. baumannii, increased mortality rates from multidrug-resistant A. pittii and A. nosocomialis infections were reported in a US hospital [2] . Carbapenem resistance in A. pittii and A. nosocomialis has been reported in many countries [3, 4] and is mediated by carbapenemase production (i.e. OXA-23, OXA-58, IMP-1, IMP-4, SIM-1 and PER-1), overexpression of efflux pumps and reduced expression of outer membrane proteins (OMPs) (i.e. OprD and CarO) [3, 5, 6] . Carbapenem-resistant A. pittii and carbapenemresistant A. nosocomialis isolates have not been reported from Thailand.
Thus, we investigated the prevalence and molecular mechanisms of carbapenem resistance in A. pittii and A. nosocomialis among Acb complex isolates from Thailand.
METHODS

Bacterial isolates and species identification
A total of 346 Acb complex isolates were isolated from individual patients at the King Chulalongkorn Memorial Hospital, Bangkok, Thailand, from 2010 to 2011. The species were identified using gyrB multiplex PCR as previously described [7] .
Antibiotic susceptibility testing
The minimum inhibitory concentrations (MICs) of imipenem (Apollo Scientific, UK) and meropenem (SigmaAldrich, Germany) were determined by the agar dilution method and were interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [8] . Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used as reference control isolates for antibiotic susceptibility testing.
Detection of carbapenemase genes
Multiplex PCR for serine carbapenemase genes was used to detect bla OXA-51-like , bla OXA-23-like , bla OXA-24-like , bla OXA-58-like , bla OXA-143-like and bla OXA-235-like [9] . Multiplex PCR for other intrinsic bla OXA genes in Acinetobacter spp. was used to detect bla OXA-134-like , bla OXA-211-like , bla OXA-213-like , bla OXA-214 and bla OXA-228-like [10] . Multiplex PCR for metallo-carbapenemase genes was used to detect bla IMP-like , bla-VIM-like , bla GIM-like , bla SIM-like and bla SPM-like [11] . The bla NDM-like , bla OXA-48-like and bla KPC-like genes were also detected by using another multiplex PCR as previously described [12] . Entire bla OXA-23 , bla OXA-58 and bla IMP genes were amplified and sequenced using the BigDye Terminator V3.1 cycle sequencing kit by 1st Base DNA sequencing service, Malaysia. All of the primers used in this study are listed in Table S1 (available in the online version of this article).
Detection of genetic environment of carbapenemase genes
The insertion sequences that were present upstream or downstream of carbapenemase genes were detected by PCR mapping and DNA sequencing.
OMP profiles
The OMPs were extracted using ultracentrifugation (Beckman-Coulter) as previously described [13, 14] . The OMP profiles were studied by SDS-PAGE. The relative expressions of OMP (CarO, 33-36 kDa and 43 kDa) were calculated and compared to those of A. baumannii ATCC 19606. Reduction in OMP expression was defined as the relative expression of OMPs <0.7 when compared to A. baumannii ATCC 19606, as previously described [14] .
Expression of efflux pumps
Overexpression of efflux pump activities was detected using efflux pump inhibitors including carbonyl cyanide m-chlorophenyl hydrazone (CCCP) (Sigma-Aldrich, Germany) and reserpine (Himedia, India). Overexpression of the efflux pump was defined as the reduction of imipenem or meropenem MICs at least fourfold in the presence of inhibitors. The efflux pump genes, adeE and adeY, were detected by PCR assay and their expression levels were evaluated by RT-PCR. The expression levels of adeE and adeY were compared to that of 16S rRNA for each strain. The expression of efflux pump genes was done in triplicate. The relative expression levels of adeE and adeY from A. pittii isolates were compared to those of each isolate and carbapenem-susceptible A. pittii AP3 using one-way ANOVA. Overexpression of efflux pumps was defined as a higher relative expression level when compared to AP3 (P value <0.05).
RESULTS
Species identification
Of the 346 Acb complex isolates, 305 (88.1 %) were identified as A. baumannii, 22 (6.4 %) were identified as A. pittii and 19 (5.5 %) were identified as A. nosocomialis. (Table 1) . Additionally, bla OXA-58-like was also detected in three carbapenem-susceptible A. pittii isolates (Table 1) . bla OXA-213-like was found in 18 A. pittii isolates but not in A. nosocomialis isolates (Table S2 ). All five carbapenem-resistant A. nosocomialis isolates carried bla OXA-23-like (Table 1) . No carbapenemase genes were found in carbapenem-susceptible A. nosocomialis. No bla OXA-51-like , bla OXA-24-like , bla OXA-143-like , bla OXA-235-like , bla OXA-211-like , bla OXA-214-like , bla OXA-228-like , bla OXA-48-like , bla NDM-like , bla KPC-like or other metallo-carbapenemase genes were found in this study. Nucleotide sequences for entire bla OXA genes revealed that A. pittii AP1, AP7 and AP8 carried bla OXA-58 whereas A. pittii AP14 carried bla OXA-96 (Table 1 ). The bla OXA-23-like in A. pittii and A. nosocomialis was bla OXA-23 ( Table 1 ). The bla IMP-like in A. pittii AP1 was bla IMP-14a . We believe that we are the first to report carbapenemase genes in A. pittii and A. nosocomialis Thai isolates, especially carbapenem-resistant A. pittii, which has both bla OXA-58 and bla IMP-14a . 23 . These results suggest that reduced OMPs may not be the major mechanism for carbapenem resistance in A. pittii and A. nosocomialis. Aside from carbapenemase production and reduction of OMPs, we believe that other mechanisms may be involved in carbapenem resistance in A. pittii and A. nosocomialis. Thus, the overexpression of efflux pumps was investigated in the next experiment.
Carbapenem susceptibility
Genetic environment of carbapenemase genes
Overexpression of efflux pumps
No overexpression of efflux pump activity was detected in A. pittii and A. nosocomialis isolates using CCCP or reserpine (data not shown). Since the expression levels of the efflux pump genes adeE and adeY play a role in carbapenem resistance in Acinetobacter spp., we assessed the expression of these genes using RT-PCR. The genes adeE and adeY were present in all eight A. pittii isolates but were absent in A. nosocomialis isolates ( Table 1) . The adeE and adeY expression levels in A. pittii isolates are shown in Fig. 1(a, b) , respectively. Overexpression of adeE was found in three carapenem-resistant A. pittii isolates (AP1, AP4 and AP16) when compared to carbapenem-susceptible A. pittii AP3 (P<0.05). Carbapenem-resistant A. pittii isolates carrying bla OXA-58 or bla OXA-96 (AP1 and AP14, respectively) showed higher expression levels of adeE than those of carbapenem-susceptible isolates carrying bla OXA-58 (AP7, AP and AP17) (Fig. 1a) . Although bla OXA-23 carrying A. pittii isolate AP16 and AP23 showed a higher expression level of adeE (P<0.05) than isolate AP4, their carbapenem MICs were indifferent ( Table 1) . Overexpression of adeY (P<0.05) was found in two A. pittii isolates (AP4 and AP8) when compared to isolate AP3 (Fig. 1b) . Although A. pittii AP8 carrying bla OXA-58 showed higher adeY expression than those of A.pittii AP7 and AP17, their carbapenem MICs were the same. A. pittii AP4 carrying isolate bla OXA-23 showed higher adeY expression than isolates AP16 and AP23, but their carbapenem MICs were not different. These results suggest that overexpression of adeE may play a role in carbapenem resistance in A. pittii.
DISCUSSION
The emergence of non-baumannii Acinetobacter isolates in human clinical specimens has been reported worldwide [2, 15] . The prevalence of A. pittii in our study (6.4 %) was similar to that found in other studies conducted in the [6] and Singapore (9.3 %) [17] . However, the study conducted in Japan (29 %) had different prevalence rates compared to our study [18] . The prevalence of A. nosocomialis in the present study (5.5 %) was similar to that in reports from the USA (2 %) [2] , Germany (2.1 %) [19] and the southern part of Thailand (8.1 %) [16] . This prevalence was markedly lower than that found in Japan (18 %) [18] . All of these studies used rpoB sequences to identify the species; however, the study from Germany used gyrB multiplex PCR to identify the species [19] . The difference in prevalence of A. pittii and A. nosocomialis may be due to the different identification methods used. Although gyrB multiplex PCR was less accurate in indentifying Acinetobacter species compared to rpoB sequencing, it is the most appropriate method for identifying the Acb complex [20] . In addition, gyrB multiplex PCR is available and can be used to process many isolates at the same time. Because of this, we used gyrB multiplex PCR to identify the isolate species.
According to a report in 2017 from the National Antimicrobial Resistance Surveillance Center, Thailand (NARST), the imipenem and meropenem susceptibility rates of Acb complex were 29.6 and 30.2 %, respectively [21] . In our study, 88.1 % of the Acb complex isolates belonged to A. baumannii. Thus, it is likely that most of the resistance reported in the NARST report is also due to resistance in A. baumannii rather than A. pittii or A. nosocomialis. In this study, the prevalences of carbapenem resistance in A. pittii and A. nosocomialis (22.7 and 26.3 %, respectively) were quite different from those reported from South Korea (53.3 and 4 %, respectively) [6] , Taiwan (33.3 and 5.7 %, respectively) [15] , Singapore (38.9 and 34.8 %, respectively) [17] and Latin America (20 and 50 %, respectively) [5] . On the other hand, no carbapenem resistance was found in A. pittii and A. nosocomialis isolates from Germany [19] . Therefore, carbapenems would be effective for treatment of A. pittii and A. nosocomialis infections in Germany.
The most common carbapenemases in carbapenem-resistant A. baumannii from Thailand and worldwide were found to be OXA-23 and OXA-58 [14, 22, 23] . The carbapenemase genes found in A. pittii and A. nosocomialis from our study were bla OXA-58 , bla OXA-96 and bla OXA-23 . These results suggest that there is a transfer of these genes between Acinetobacter species. Although bla OXA-213 was considered to be the naturally occurring oxacillinase gene in A. calcoaceticus, it was not shown to contribute to carbapenem resistance [10, 24] . Since bla OXA-213 was found in 81.8 % of A. pittii isolates, the transfer of this gene between Acb complexes should be monitored. Metallo-carbapenemase genes including bla SIM and bla IMP were found among carbapenem-resistant A. pittii and A. nosocomialis isolates from Japan and South Korea [6, 25] , while bla OXA-58 and bla OXA-23 were found in A. pittii and A. nosocomialis isolates from China [26, 27] , Singapore [17] and Spain [28] . Carbapenem-resistant A. pittii isolates co-harbouring many carbapenemase genes have been reported in Australia (carrying bla OXA-96 and bla IMP-4 ) [29] , Japan (carrying bla OXA-58 and bla IMP-1 ) [18] and Malaysia (carrying bla OXA-58 and bla NDM-1 ) [30] . This study is the first to report an A. pittii isolate (AP1) co-harbouring bla OXA-58 and bla IMP-14a . bla IMP-14a was present in two imipenem-susceptible Klebsiella pneumoniae isolates from a university hospital in Thailand [31] . These data suggest that there has been a transfer of bla IMP-14a between K. pneumoniae and A. pittii isolates from Thailand. Although, no carbapenem-resistant A. pittii was found in a study in Germany, there were many carbapenem-susceptible isolates that carried the bla OXA-23-like or bla OXA-58-like genes [19] . Similar to our study, three carbapenem-susceptible A. pittii carried bla OXA-58 . These data suggest that A. pittii may be a silent source for bla . In order to carry out the necessary surveillance, aside from doing routine carbapenem susceptibility tests, identification of the species and detection of carbapenemase genes in Acinetobacter species should be considered and performed.
The ISAba3 gene flanked bla OXA-58 and was found in carbapenem-resistant A. pittii and carbapenem-susceptible A. pittii isolates in our study. These results are similar to the report by Zander et al. [3] , which showed that there was no difference in nucleotide sequences of ISAba3 upstream bla OXA-58 between carbapenem-resistant and -susceptible isolates. These results suggest that other mechanisms may be involved in carbapenem resistance in A. pittii. However, many IS elements, including ISAba2, IS1008 and IS1006, have been reported to provide strong promoters to bla OXA-58 in carbapenem-resistant Acinetobacter species [26, 32] . Furthermore, the duplication of bla OXA-58 is a possible reason for the differences in carbapenem MICs in A. pittii as previously reported [33] . ISAba1 upstream of bla OXA-23 was found in all carbapenem-resistant A. pittii and A. nosocomialis carrying bla OXA-23 . These results are similar to many previous studies which showed that ISAba1 plays a role in carbapenem resistance in Acinetobacter species by providing a strong promoter [3, 34] . No overexpression of efflux pump activity was detected in A. pittii and A. nosocomialis using efflux inhibitors. This finding suggests that using efflux inhibitors may be less sensitive than RT-PCR for the detection of efflux pump activity. It has been reported that the overexpression of AdeDE and AdeXYZ efflux pumps is involved in carbapenem resistance in A. pittii and A. nosocomialis [42] . AdeE and AdeY efflux transporters are encoded by adeE and adeY genes, respectively [42] . These transporters are an important part of the pumps. A report by Chu et al. [43] showed that genes adeE and adeY were detected in 70 and 90 % of A. pittii isolates, respectively, whereas these genes were found in 4 % of A. nosocomialis. In our study, adeE and adeY were present in all eight A. pittii carrying carbapenemase gene isolates, but they were absent in all five carbapenem-resistant A. nosocomialis isolates. Overexpression of the adeE efflux pump gene combined with carbapenemase (OXA-58, IMP14a or OXA-96) production conferred a high level of carbapenem MICs in A. pittii. Overexpression of adeY did not appear to contribute to carbapenem resistance in A. pittii isolates. This suggests that the AdeY efflux pump is not a major mechanism of carbapenem resistance in A. pittii.
Moreover, from this study, the AdeE and AdeY efflux transporters do not appear to play a role in carbapenem resistance in A. nosocomialis.
In conclusion, mechanisms of carbapenem resistance in A. pittii and A. nosocomialis Thai isolates were mediated by carbapenemase production (OXA-23, OXA-58, OXA-96 and IMP-14a) and overexpression of AdeE efflux pump. This study is the first to report carbapenem-resistant A. pittii isolate co-harbouring bla OXA-58 and bla IMP-14a . Apart from A. baumannii, carbapenem resistance in A. pittii and A. nosocomialis should be considered in Thailand. Additional investigation is needed to determine whether carbapenemase genes are transferred among A. baumannii, A. pittii and A. nosocomialis. 
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